However, this tumor suppressor-like property of Nrf2 was not fully supported by notions that many human cancers showed an overactivation of Nrf2 resulted from gain-of-functional mutation of the Nrf2 genes, including cancers of esophagus, lung, larynx, skin, etc. [12,15]. This evidence concerns the gene NFE2L2 and neoplasm.